14 June 2019
A bill establishing a procedure for regulation of prices for vital and essential medicines has become law. A version of the document signed by Russian President Vladimir Putin has been published on the official website of legal information.
The law stipulates binding reregistration of producers’ maximum sale prices for vital and essential drugs if their price has been reduced in a producing country and in the states where these medicines have been registered.
It also envisages that the producer’s registered maximum sale price for such drugs may be rerecorded increasingly not more frequently than once a year.
Amendments will be introduced into the law on medicine circulation.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024
The Future of Pharmacy: How Advancements in Technology Are Transforming the Field
23 April 2024
Analysis Forecasts Up to 16.5% of Population Will Have Chronic Kidney Disease by 2032
23 April 2024